TB-402 Completed Phase 2 Trials for Total Knee Replacement Surgery Prevention

Indications	Status	Purpose	Phase
DBCOND0042350 (Total Knee Replacement Surgery)	Completed	Prevention	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00793234	Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery	Enoxaparin (DB01225) TB-402 (DB06050)